EBV in T-/NK-Cell Tumorigenesis-Reference-Cited by-同舟云学术

EBV in T-/NK-Cell Tumorigenesis

Published:2018 Issue: Volume: Page:459-475
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Kimura Hiroshi

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-10-7230-7_21

Reference106 articles.

1. Alfieri C, Joncas JH (1987) Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. J Virol 61:3306–3309

2. Anagnostopoulos I, Hummel M, Kreschel C, Stein H (1995) Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744–750

3. Aozasa K, Takakuwa T, Hongyo T, Yang WI (2008) Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 87:110–117

4. Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594–599

5. Chan JKC, Jaffe ES, Ralfkiaer E, Ko YH (2008a) Aggressive NK-cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Press, Lyon

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of pre-treatment T lymphocyte subsets in patients with extranodal natural killer/T-cell lymphoma;Annals of Hematology;2024-08-28

2. A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry;Annals of Medicine;2024-03-19

3. Understanding the Role of EBV Infection in Lymphomagenesis;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Therapeutic challenges in peripheral T-cell lymphoma;Molecular Cancer;2024-01-04

5. EBV and MS: The evidence is growing stronger;Cell;2023-12